Related Experiment Video
Updated: Feb 17, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell
Erika A Newman1, Sahiti Chukkapalli2, Daniela Bashllari2
1Department of Surgery, C.S. Mott Children and Women's Hospital, Mott Solid Tumor Oncology Program, The University of Michigan Medical School, Ann Arbor, MI, USA. eanewman@med.umich.edu.
Abstract:
Neuroblastoma is a cancer of neural crest stem cell (NCSC) lineage. Signaling pathways that regulate NCSC differentiation have been implicated in neuroblastoma tumorigenesis. This is exemplified by MYCN oncogene targets that balance proliferation, differentiation, and cell death similarly in normal NCSC and in high-risk neuroblastoma. Our previous work discovered a survival mechanism by which MYCN-amplified neuroblastoma circumvents cell death by upregulating components of the error-prone non-canonical alternative nonhomologous end-joining (alt-NHEJ) DNA repair pathway. Similar to proliferating stem cells, high-risk neuroblastoma cells have enhanced DNA repair capacity, overcoming DNA damage with higher repair efficiency than somatic cells. Adequate DNA maintenance is required for lineage protection as stem cells proliferate and during tumor progression to overcome oncogene-induced replication stress. On this basis, we hypothesized that alt-NHEJ overexpression in neuroblastoma is a cancer cell survival mechanism that originates from DNA repair systems of NCSC, the presumed progenitor cell of origin. A human NCSC model was generated in which inducible MYCN triggered an immortalized phenotype capable of forming metastatic neuroectodermal tumors in mice, resembling human neuroblastoma. Critical alt-NHEJ components (DNA Ligase III, DNA Ligase I, and Poly [ADP-ribose polymerase 1]) were highly expressed in normal early NCSC, and decreased as cells became terminally differentiated. Constitutive MYCN expression maintained high alt-NHEJ protein expression, preserving the expression pattern of the immature neural phenotype. siRNA knockdown of alt-NHEJ components reversed MYCN effects on NCSC proliferation, invasion, and migration. DNA Ligase III, Ligase I, and PARP1 silencing significantly decreased neuroblastoma markers expression (TH, Phox2b, and TRKB). These results utilized the first human NCSC model of neuroblastoma to uncover an important link between MYCN and alt-NHEJ expression in developmental tumor initiation, setting precedence to investigate alt-NHEJ repair mechanics in neuroblastoma DNA maintenance.
Insights
Neuroblastoma cancer cells utilize the alternative nonhomologous end-joining (alt-NHEJ) DNA repair pathway for survival. This pathway, originating from neural crest stem cells (NCSCs), is upregulated by the MYCN oncogene, promoting tumor growth and resistance to cell death.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Neuroblastoma, a cancer of neural crest stem cell (NCSC) lineage, is driven by signaling pathways regulating NCSC differentiation.
- The MYCN oncogene plays a critical role in balancing proliferation, differentiation, and cell death in both normal NCSCs and high-risk neuroblastoma.
- MYCN-amplified neuroblastoma employs a survival mechanism involving the upregulation of the alternative nonhomologous end-joining (alt-NHEJ) DNA repair pathway to circumvent cell death.
Purpose of the Study:
- To investigate the hypothesis that alt-NHEJ overexpression in neuroblastoma is a cancer cell survival mechanism originating from NCSC DNA repair systems.
- To establish and utilize a human NCSC model to study the role of MYCN and alt-NHEJ in neuroblastoma development.
Main Methods:
- Generation of a human NCSC model with inducible MYCN expression, leading to an immortalized phenotype and metastatic tumor formation in mice.
- Analysis of critical alt-NHEJ components (DNA Ligase III, DNA Ligase I, PARP1) expression in normal NCSCs during differentiation and in MYCN-expressing cells.
- Utilizing siRNA knockdown of alt-NHEJ components to assess their impact on NCSC proliferation, invasion, migration, and neuroblastoma marker expression.
Main Results:
- Critical alt-NHEJ components were highly expressed in early normal NCSCs and decreased with terminal differentiation.
- Constitutive MYCN expression maintained high alt-NHEJ protein levels, preserving the immature neural phenotype.
- siRNA-mediated knockdown of alt-NHEJ components reversed MYCN-driven proliferation, invasion, and migration, and significantly decreased neuroblastoma markers (TH, Phox2b, TRKB).
Conclusions:
- The study establishes a link between MYCN and alt-NHEJ expression in neuroblastoma initiation, suggesting a developmental origin for this cancer survival mechanism.
- Overexpression of alt-NHEJ components in neuroblastoma represents a survival strategy derived from NCSC DNA repair pathways.
- These findings highlight the importance of alt-NHEJ repair mechanics in neuroblastoma DNA maintenance and provide a basis for future therapeutic strategies.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:43An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
Published on: August 23, 2016
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Abnormal Proliferation
Canonical Wnt Signaling Pathway